Jim Cramer on AstraZeneca: “We Want Every Drug Stock”

On Tuesday, we’re backmost successful dense net rotation. We’ve got DuPont, Coca-Cola, CVS Health, AstraZeneca, Datadog, and S&P Global report… Oh, also, AstraZeneca, we privation each cause stock. They’re each working.

Photo by Adam Nowakowski connected Unsplash

AstraZeneca PLC (NASDAQ:AZN) manufactures medicine medicines for oncology, cardiovascular, respiratory, and uncommon diseases. During the January 30 episode, a caller mentioned that they were contemplating selling their presumption successful the company’s banal for nett and buying ABBV. Cramer replied:

I similar AstraZeneca precise much. And that crab franchise turned retired to beryllium a batch stronger than I thought. I deliberation you should clasp onto that. AbbVie reports this week. I expect a precise bully quarter. I similar the dividend, but I deliberation AstraZeneca has got a amended portfolio astatine this precise moment.

While we admit the imaginable of AZN arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the champion short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published astatine Insider Monkey.